Cargando…

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

PURPOSE: A Regional Technical Commission was set in 2017 by Veneto region (Italy) to provide opinions and recommendations on drug prescriptions and to implement treatment-pathway guidelines for severe asthma. In this observational study, we describe the first structured, integrated, multidisciplinar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tognella, Silvia, Micheletto, Claudio, Roggeri, Alessandro, Polese, Guido, Artioli, Denise, Senna, Gianenrico, Caminati, Marco, Roggeri, Daniela Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370491/ https://www.ncbi.nlm.nih.gov/pubmed/34413653 http://dx.doi.org/10.2147/JAA.S309740

Ejemplares similares

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues
por: Roggeri, Alessandro, et al.
Publicado: (2016)

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
por: Roggeri, Alessandro, et al.
Publicado: (2014)

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
por: Roggeri, Daniela Paola, et al.
Publicado: (2017)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015)

Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study
por: Roggeri, Daniela Paola, et al.
Publicado: (2016)

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020)

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
por: Caminati, Marco, et al.
Publicado: (2022)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Uncontrolled Asthma: Unmet Needs in the Management of Patients
por: Caminati, Marco, et al.
Publicado: (2021)

Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy
por: Magnoni, Maria Sandra, et al.
Publicado: (2015)

Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
por: Magnoni, Maria Sandra, et al.
Publicado: (2017)

Upsides and downsides of a telecounselling model of integrated asthma management between general practitioners and specialists
por: Furci, Fabiana, et al.
Publicado: (2022)

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
por: Vianello, A., et al.
Publicado: (2019)

Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
por: Caminati, Marco, et al.
Publicado: (2020)

Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic
por: Olivero, Guendalina, et al.
Publicado: (2023)

Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity
por: Dal Negro, Roberto W, et al.
Publicado: (2013)

A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results
por: Joppi, Roberta, et al.
Publicado: (2015)

Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
por: Benoni, Roberto, et al.
Publicado: (2022)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Asthma management among allergists in Italy: results from a survey
por: Magnoni, M. S., et al.
Publicado: (2017)

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
por: Roggeri, Daniela Paola, et al.
Publicado: (2014)

Oral health in asthmatic patients: a review: Asthma and its therapy may impact on oral health
por: Gani, Federica, et al.
Publicado: (2020)

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
por: Caminati, Marco, et al.
Publicado: (2021)

TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD
por: Furci, Fabiana, et al.
Publicado: (2023)

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
por: Caminati, Marco, et al.
Publicado: (2021)

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
por: Maule, Matteo, et al.
Publicado: (2023)

Physicians’ prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy
por: Passalacqua, Giovanni, et al.
Publicado: (2020)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

Minimal clinically important difference for asthma endpoints: an expert consensus report
por: Bonini, Matteo, et al.
Publicado: (2020)

Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System
por: Pittaluga, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d42gc6vt8dcio3e2289ht3gsdp